Abstract
FGF21 is a novel member of the FGFs family, is mainly expressed in liver and it functions as a potent activator of glucose uptake on adipocytes. When over expressed in transgenic mice, it protects animals from diet-induced obesity and its administration to diabetic rodents and monkeys lowers blood glucose and triglyceride levels. Recently, increased levels of FGF21 have been identified as an independent risk factor related with metabolic syndrome. A review of the relevant roles of FGF21 in metabolism is presented here.
Keywords: Fibroblast growth factor 21, Glucose, Energy balance, Insulin, Metabolic syndrome, Type 2 diabetes mellitus
Current Diabetes Reviews
Title: The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
Volume: 5 Issue: 4
Author(s): Daniel Cuevas-Ramos, Paloma Almeda-Valdes, Carlos A. Aguilar-Salinas, Gabriel Cuevas-Ramos, Andres A. Cuevas-Sosa and Francisco J. Gomez-Perez
Affiliation:
Keywords: Fibroblast growth factor 21, Glucose, Energy balance, Insulin, Metabolic syndrome, Type 2 diabetes mellitus
Abstract: FGF21 is a novel member of the FGFs family, is mainly expressed in liver and it functions as a potent activator of glucose uptake on adipocytes. When over expressed in transgenic mice, it protects animals from diet-induced obesity and its administration to diabetic rodents and monkeys lowers blood glucose and triglyceride levels. Recently, increased levels of FGF21 have been identified as an independent risk factor related with metabolic syndrome. A review of the relevant roles of FGF21 in metabolism is presented here.
Export Options
About this article
Cite this article as:
Cuevas-Ramos Daniel, Almeda-Valdes Paloma, Aguilar-Salinas A. Carlos, Cuevas-Ramos Gabriel, Cuevas-Sosa A. Andres and Gomez-Perez J. Francisco, The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism, Current Diabetes Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339909789804396
DOI https://dx.doi.org/10.2174/157339909789804396 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Functional, Genetic and Biochemical Biomarkers of Peripheral Arterial Disease
Current Medicinal Chemistry Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants
Current Pharmaceutical Design Genomic and Epigenetic Complexity of the FOXF1 Locus in 16q24.1: Implications for Development and Disease
Current Genomics The Role of Coagulation and Fibrinolysis in the Pathogenesis of Acute Lung Injury
Current Respiratory Medicine Reviews Chemotherapy and Targeted Agents for Elderly Women with Advanced Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery The Vascular Component of Alzheimer`s Disease
Current Neurovascular Research Endothelin-1 Impairs Retrograde Axonal Transport and Leads to Axonal Injury in Rat Optic Nerve
Current Neurovascular Research Resistin and Oxidative Stress as Markers of Atherosclerosis in Obstructive Sleep Apnea
Current Respiratory Medicine Reviews Prognostic Role of miRNAs in Coronary Artery Disease
Current Topics in Medicinal Chemistry Selective Serotonin Reuptake Inhibitors in Pregnancy
Current Medicinal Chemistry Cardiac SPECT-CT and PET-CT Imaging
Current Medical Imaging Patent Selections
Recent Patents on Cardiovascular Drug Discovery Hypomagnesaemia/Hypokalemia Associated with the Use of Esomeprazole
Current Drug Safety Lipid based Nanocarriers for Oral Delivery of Cancer Chemotherapeutics: An Insight in the Intestinal Lymphatic Transport
Drug Delivery Letters Cancer and Treatment Modalities
Current Cancer Therapy Reviews GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting
Current Molecular Pharmacology The Emergence of Selective 5-HT2B Antagonists Structures, Activities and Potential Therapeutic Applications [General Reviews]
Mini-Reviews in Medicinal Chemistry Coronary Artery Disease and Endothelial Dysfunction: Novel Diagnostic and Therapeutic Approaches
Current Medicinal Chemistry Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Genes and Hypertension
Current Pharmaceutical Design